YTHDF2 and acute myeloid leukemia: Further, in a study by Chen Zi et al. in adult AML patients, YTHDF2 mRNA expression is shown to be elevated in t (8;21) AML patients and is associated with a higher risk of relapse and inferior relapse-free survival [16].